Burkitt and Burkitt-Like Lymphomas: a Systematic Review.

Current Oncology Reports
Khalil SalehVincent Ribrag

Abstract

Burkitt's lymphoma and its leukemic form (Burkitt cell acute lymphoblastic leukemia) are a highly aggressive disease. We review the classification, clinical presentation, histology, cytogenetics, and the treatment of the disease. Burkitt's lymphoma might be associated with tumor lysis syndrome which is a potentially fatal complication that occurs spontaneously or upon initiation of chemotherapy. Major improvements were made in the treatment of pediatric and adults population using short-course dose-intensive chemotherapy regimens, usually 1 week after a prephase induction. Addition of Rituximab to chemotherapy has become a standard of care. Relapsed/refractory disease has a very poor prognosis and the benefit from autologous/allogeneic hematopoietic stem cell transplant remains uncertain. Rituximab-based short-course dose-intensive chemotherapy is the standard of care of Burkitt's lymphoma even in the immunodeficiency-related form.

References

Apr 6, 1991·Lancet·V BeralH Jaffe
Jan 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R SchwennH J Weinstein
Oct 1, 1981·Neurology·E W MasseyS C Schold
Feb 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A ReiterH Riehm
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D A ThomasH Kantarjian
Aug 3, 2000·Cancer Investigation·P C BishopW H Wilson
Aug 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G M MeadUNKNOWN UKLG LY06 collaborators
Aug 23, 2002·Current Opinion in Oncology·Otoniel Martínez-Maza, Elizabeth Crabb Breen
Jul 11, 2003·Hematology/oncology Clinics of North America·Daniel M Knowles
Nov 1, 1958·The British Journal of Surgery·D BURKITT
Jul 22, 2004·Blood·Kristie A BlumJohn C Byrd
Dec 30, 2004·East African Medical Journal·O W MwandaM L Wilson
Apr 1, 2005·Leukemia·G W van ImhoffUNKNOWN Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
Nov 15, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M DivinéUNKNOWN GOELAMS
May 18, 2006·British Journal of Haematology·Kevin W SongJoseph M Connors
May 13, 2009·Pediatric Blood & Cancer·Sam M MbulaiteyeSusan S Devesa
Jan 21, 2012·British Journal of Haematology·Ian Magrath
Feb 16, 2012·Lancet·Elizabeth M MolyneuxSimon Bailey
Dec 4, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Leena V MaramattomJames L Gajewski
Nov 15, 2013·The New England Journal of Medicine·Kieron DunleavyWyndham H Wilson
Nov 2, 2014·Blood·Dieter HoelzerUNKNOWN German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
May 28, 2015·Current Hematologic Malignancy Reports·Carla Casulo, Jonathan Friedberg
Nov 28, 2016·Hematology/oncology Clinics of North America·Kieron DunleavyWyndham H Wilson
Jan 18, 2017·Adolescent Health, Medicine and Therapeutics·Massimo DozzoRenato Bassan
Sep 15, 2018·Best Practice & Research. Clinical Haematology·Carla Casulo, Jonathan W Friedberg

❮ Previous
Next ❯

Citations

May 6, 2021·Clinical Lymphoma, Myeloma & Leukemia·Ana M Della RoccaRoberto Pontarolo
Jul 27, 2021·Clinical Case Reports·Nahal AzimiNeda Kardouni Khoozestani
Aug 18, 2020·Medicina clínica·Cristina Rubín de CélixJorge Mendoza

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.